deferoxamine has been researched along with Disease Resistance in 1 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Disease Resistance: The capacity of an organism to defend itself against pathological processes or the agents of those processes. This most often involves innate immunity whereby the organism responds to pathogens in a generic way. The term disease resistance is used most frequently when referring to plants.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nairz, M | 1 |
| Schleicher, U | 1 |
| Schroll, A | 1 |
| Sonnweber, T | 1 |
| Theurl, I | 1 |
| Ludwiczek, S | 1 |
| Talasz, H | 1 |
| Brandacher, G | 1 |
| Moser, PL | 1 |
| Muckenthaler, MU | 1 |
| Fang, FC | 1 |
| Bogdan, C | 1 |
| Weiss, G | 1 |
1 other study available for deferoxamine and Disease Resistance
| Article | Year |
|---|---|
Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cation Transport Proteins; Deferoxa | 2013 |